Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   
Dis-Chem Pharmacies Ltd.  –  JSE:DCP  
     
Prices at least 15 minutes delayed. Source: JSE Ltd.
 
Watch DCP 
Thu 30 Oct 2025, 7:14 Dis-Chem interim results August 2025
View SENS 

Revenue from contracts with customers rose by 8.7% to R21.3 billion (R19.6 billion) with gross profit ending 8.2% higher at R4.7 billion (R4.4 billion). Operating profit before interest and equity accounted earnings inclined 9% to R1.1 billion (R1.0 billion) with profit attributable to Equity holders of the parent coming in at R633.1 million (R577.7 million)). Additionally, headline earnings per share went up to 73.8c per share (67.7c per share).

Dividend declaration
Notice is hereby given that a gross interim cash dividend of 29.41734 cents per share, in respect of the interim period ended 31 August 2025 has been declared based on 40% of headline earnings.

Directorate
Mr Saul Saltzman is formally resigning from his position as Executive Director of the Company effective 27 February 2026. Following his resignation, Mr Saltzman will remain on the Board (effective 27 February 2026) as a Non-Independent, Non-Executive Director continuing to contribute actively to the Company's strategic direction.

Company outlook
For the two-month period 1 September to 26 October 2025, Group revenue grew by 9.7% over the prior comparable period.

The Group expects that the consumer will remain constrained due to the current economic climate. Following the establishment of X, bigly labs, the Group’s innovation hub, there’s a shift to data-led commercial decisioning that places the customer at the centre of the ecosystem experience.

Linked to our strategic areas of focus, the following business priorities will continue through FY26 and beyond:
• Continued acceleration of space identification and new store openings towards achieving the target of 137 000m². Including the 20 stores already trading in FY2026, 32 retail pharmacy stores are planned for the year.
• Store of the future design to facilitate true omnichannel retailing and healthcare delivery, incorporating ecosystem elements aligned to brand architecture, with the first store trading in Q1 FY2027
• Continue to evolve and simplify promotional mechanisms following the successful first phase deployment with the launch of Better Rewards across October month-end.
• Continued focus on staffing framework 2.0 in the retail business
• Continue the working capital unlock to achieve R500 million by the end of FY2026
• Reimagine online retailing and healthcare access, with the new app to be launched midyear FY2027
• Build increased customer engagement with enhanced value creation driving customer lifetime value across the ecosystem
• Following the launch of the Capitec strategic partnership, add synergistic brands to provide access to mass market South Africa and improve Better Rewards’ value proposition
• People and Culture: employees as our priority customers with a commitment to improve their health enabling them to access differentiated rewards, creating 20,000 purpose-aligned ambassadors delivering on the ecosystem strategy

 
Portfolio  
Watch List  
Recently viewed


 
 
* Price data source: JSE Ltd. All other statistics calculated by ProfileData.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData


Follow us on: